Screening-confirmation approach for urinary alpelisib by silver-nanorod enabled portable SERS platform and LC–MS validation - Analytical and Bioanalytical Chemistry

Screening-confirmation approach for urinary alpelisib by silver-nanorod enabled portable SERS platform and LC–MS validation - Analytical and Bioanalytical Chemistry

Summary

Alpelisib, a selective PI3Kα inhibitor, benefits from reliable quantitative measurements to support exposure assessment and dose individualization. He

Original reporting

Open original source

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage